SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-22-022359
Filing Date
2022-08-12
Accepted
2022-08-12 16:16:08
Documents
39
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 703098
2 ex31-1.htm EX-31.1 17833
3 ex31-2.htm EX-31.2 18337
4 ex32-1.htm EX-32.1 7334
5 ex32-2.htm EX-32.2 7109
  Complete submission text file 0001493152-22-022359.txt   3404300

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE immx-20220630.xsd EX-101.SCH 22651
7 XBRL CALCULATION FILE immx-20220630_cal.xml EX-101.CAL 33186
8 XBRL DEFINITION FILE immx-20220630_def.xml EX-101.DEF 103891
9 XBRL LABEL FILE immx-20220630_lab.xml EX-101.LAB 262533
10 XBRL PRESENTATION FILE immx-20220630_pre.xml EX-101.PRE 186748
33 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 417900
Mailing Address 10573 W. PICO BLVD. #58 LOS ANGELES CA 90064
Business Address 11400 WEST OLYMPIC BLVD. SUITE 200 LOS ANGELES CA 90064 (888) 958-1084
Immix Biopharma, Inc. (Filer) CIK: 0001873835 (see all company filings)

IRS No.: 454869378 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41159 | Film No.: 221160281
SIC: 2834 Pharmaceutical Preparations